Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Anaesthesia ; 70(7): 859-76, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25950621

ABSTRACT

Guidelines are presented for the organisational and clinical peri-operative management of anaesthesia and surgery for patients who are obese, along with a summary of the problems that obesity may cause peri-operatively. The advice presented is based on previously published advice, clinical studies and expert opinion.


Subject(s)
Anesthesia , Obesity , Perioperative Care , Female , Humans , Male , Anesthesia/methods , Anesthesiology , Bariatric Medicine , Ireland , Obesity/surgery , Perioperative Care/methods , Societies, Medical , United Kingdom
3.
Crit Care Resusc ; 4(4): 271-80, 2002 Dec.
Article in English | MEDLINE | ID: mdl-16573440

ABSTRACT

OBJECTIVE: To review the use of indomethacin in the management of traumatic brain injury. DATA SOURCES: Articles reported from 1966 to 2001 and identified through a MEDLINE search of the English language literature on the use of indomethacin in traumatic brain injury. SUMMARY OF REVIEW: Traumatic brain injury (TBI) is a frequent cause of mortality and morbidity in patients with head injury. The use of indomethacin in treating raised intracranial pressure (ICP) secondary to TBI is controversial. Clinical studies suggest that it may be useful in the management of intracranial hypertension, when used in combination with standard techniques, by decreasing cerebral blood flow and reducing ICP during the restoration of the blood brain barrier. Its unique mechanism of action may be due to precapillary vasoconstriction, which reduces the transcapillary transfer of fluid into the cerebral extracellular space. However, large, prospective, randomised and controlled studies have not yet been performed to confirm its benefit in patients with TBI. CONCLUSIONS: Indomethacin should only be considered as an experimental therapy for refractory intracranial hypertension in TBI patients, as current evidence is not available to support its routine use in the management of an elevated ICP. Its use in patients with cerebral vasospasm, renal failure, bleeding disorders, peptic ulceration and coagulopathies is contraindicated.

4.
J Forensic Sci ; 46(5): 1199-210, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11569565

ABSTRACT

The Mixed Stain Study 1 (MSS1, Apr.-Nov. 1997) and Mixed Stain Study 2 (MSS2, Jan.-May 1999) evaluated multiplexed short-tandem repeat (STR) DNA typing systems with samples containing DNA from more than one source. These interlaboratory challenge studies evaluated forensic STR measurement, interpretation, and reporting practice using well-characterized samples of very different analytical difficulty. None of the relatively few errors reported in either exercise resulted in a false identification of a reference source; several errors in evaluating the unknown source in three-source samples would hinder matching the profile in any archival database. None of the measurement anomalies reported is associated with any particular STR multiplex; all DNA amplification anomalies are associated with inefficient DNA extraction, inaccurate DNA quantitation, and/or analytical threshold policies.


Subject(s)
DNA Fingerprinting , Tandem Repeat Sequences/genetics , Blood , Databases, Factual , Forensic Medicine/methods , Humans , Observer Variation , Polymerase Chain Reaction , Reproducibility of Results , Semen , Specimen Handling
5.
Fresenius J Anal Chem ; 370(2-3): 213-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11451239

ABSTRACT

The Standard Reference Materials Program at the US National Institute of Standards and Technology (NIST) has three human DNA standard reference materials (SRM 2390, SRM 2391a, and SRM 2392) currently available [1, 2]. Both the DNA profiling SRM 2390 and the polymerase chain reaction (PCR)-based DNA profiling SRM 2391a are intended for use in forensic and paternity identifications, for instructional law enforcement, or for non-clinical research purposes and are not intended for clinical diagnostics. The mitochondrial DNA (mtDNA) SRM 2392 is to provide standardization and quality control when performing PCR and sequencing any segment or the entire 16,569 base pairs that comprise human mitochondrial DNA. SRM 2392 is designed for use by the forensic, medical, and toxicological communities for human identification, disease diagnosis or mutation detection.


Subject(s)
DNA, Mitochondrial/standards , DNA/standards , Polymerase Chain Reaction/standards , Reference Standards , DNA/analysis , DNA, Mitochondrial/analysis , Genome, Human , Humans , Polymerase Chain Reaction/methods
6.
J Forensic Sci ; 42(5): 897-906, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9304839

ABSTRACT

An interlaboratory comparison of typing results for Short Tandem Repeats (STRs) at the GenBank loci HUMCSF1PO, HUMTPOX, HUMTH01, and HUMVWFA31 using the "CTT triplex" and "CTTv quadruplex" has been evaluated. These STRs all have a nominal four basepair (bp) repeat. Seven different samples were distributed to 41 laboratories. The 34 laboratories that returned results used a wide variety of analytical systems. Comparable results were obtained for all samples at all loci when results were reported as an allelic name. Raw sizing results obtained from internal-lane sizing standards differed by nearly five bp at some loci. Many different factors contribute to this observed sizing variability, including choice of sizing standards and matrix composition. Although sizing results can be made more comparable by locus-specific offsets or calibration to a comprehensive set of alleles at each locus, samples typed to the allelic name can now be validly compared regardless of analytical method. Interlaboratory comparison of raw allelic size remains problematic.


Subject(s)
DNA Fingerprinting/standards , DNA/analysis , Laboratories/standards , Repetitive Sequences, Nucleic Acid , Algorithms , Calibration , Evaluation Studies as Topic , Gene Amplification , Humans , Polymerase Chain Reaction , Reproducibility of Results , United States
7.
Appl Theor Electrophor ; 6(1): 33-41, 1996.
Article in English | MEDLINE | ID: mdl-9072079

ABSTRACT

The 100-1,000 basepair size typical of PCR-amplified DNA fragments demands high resolution electrophoretic gels for the adequate characterization of small differences among samples. We have studied the behavior of a number of commercial sizing ladders in three classes of separation systems: polyacrylamides with discontinuous buffer, proprietary acrylamides with continuous buffer, and agarose-like materials with continuous buffer. None of the ladders examined perform adequately in any of these systems using vendor-supplied nominal ladder component basepair sizes. All ladders successfully typed D1S8O alleles after calibration with the allelic ladder (replacing the nominal size values with the least squares estimate of allele/matrix-specific apparent sizes). Some ladders and matrices are qualitatively better than others. No one ladder proved consistently better than others; a polyacrylamide gel with ribose modifier provided the most precise results in this study. Appropriately calibrated electrophoretic apparent sizes must be used for results to be validly exchanged among laboratories. Appropriate allelic ladders or a well defined subset of known alleles can serve as the calibration system.


Subject(s)
Acrylamides/chemistry , DNA/classification , Electrophoresis, Agar Gel/methods , Electrophoresis, Polyacrylamide Gel/methods , Gels , Sepharose/analogs & derivatives , Alleles , Genetic Markers , Humans , Repetitive Sequences, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...